Shares of Sotera Health (NASDAQ:SHC - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five ratings firms that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $15.80.
A number of equities research analysts have recently issued reports on SHC shares. Wall Street Zen downgraded Sotera Health from a "buy" rating to a "hold" rating in a report on Saturday. Piper Sandler lowered their target price on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. The Goldman Sachs Group upgraded shares of Sotera Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $14.00 to $17.00 in a research report on Monday, May 5th. Finally, Barclays decreased their price target on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a report on Thursday, April 10th.
Check Out Our Latest Research Report on SHC
Institutional Trading of Sotera Health
Several large investors have recently added to or reduced their stakes in SHC. Vanguard Group Inc. raised its stake in shares of Sotera Health by 1.2% during the fourth quarter. Vanguard Group Inc. now owns 14,923,546 shares of the company's stock valued at $204,154,000 after purchasing an additional 173,341 shares in the last quarter. Sculptor Capital LP raised its position in shares of Sotera Health by 80.8% during the 1st quarter. Sculptor Capital LP now owns 9,037,511 shares of the company's stock worth $105,377,000 after buying an additional 4,037,511 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in shares of Sotera Health by 5.9% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 8,045,502 shares of the company's stock worth $93,811,000 after acquiring an additional 450,761 shares during the period. TPG GP A LLC acquired a new stake in shares of Sotera Health in the 1st quarter worth approximately $79,126,000. Finally, Two Seas Capital LP boosted its holdings in shares of Sotera Health by 14.7% in the first quarter. Two Seas Capital LP now owns 3,321,136 shares of the company's stock valued at $38,724,000 after acquiring an additional 425,000 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.
Sotera Health Stock Performance
Shares of SHC stock opened at $12.30 on Friday. Sotera Health has a 12 month low of $9.53 and a 12 month high of $17.08. The firm has a market capitalization of $3.49 billion, a P/E ratio of 49.20 and a beta of 1.87. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The company's fifty day moving average price is $11.74 and its two-hundred day moving average price is $12.55.
Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.14 earnings per share for the quarter, beating analysts' consensus estimates of $0.12 by $0.02. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The firm had revenue of $254.52 million during the quarter, compared to analyst estimates of $245.56 million. During the same quarter last year, the firm earned $0.13 EPS. Sotera Health's quarterly revenue was up 2.6% on a year-over-year basis. On average, research analysts anticipate that Sotera Health will post 0.61 earnings per share for the current fiscal year.
About Sotera Health
(
Get Free ReportSotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sotera Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.
While Sotera Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
